Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Tables)

12 Months Ended

Dec. 31, 2021

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Earning Per Share

The following presents the detailed calculation of EPS:
	Year Ended December 31,
(IN MILLIONS)	2021		2020		2019
EPS Numerator––Basic
Income from continuing operations attributable to Pfizer Inc.	$	22,414	$	6,630	$	10,708
Less: Preferred stock dividends––net of tax	—		—		1
Income from continuing operations attributable to Pfizer Inc. common shareholders	22,414		6,630		10,708
Discontinued operations––net of tax	(434)		2,529		5,318
Net income attributable to Pfizer Inc. common shareholders	$	21,979	$	9,159	$	16,025
EPS Numerator––Diluted
Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions	$	22,414	$	6,630	$	10,708
Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders and assumed conversions	(434)		2,529		5,318
Net income attributable to Pfizer Inc. common shareholders and assumed conversions	$	21,979	$	9,159	$	16,026
EPS Denominator
Weighted-average number of common shares outstanding––Basic	5,601		5,555		5,569
Common-share equivalents: stock options, stock issuable under employee compensation plans convertible preferred stock and accelerated share repurchase agreements	107		77		106
Weighted-average number of common shares outstanding––Diluted	5,708		5,632		5,675
Anti-dilutive common stock equivalents(a)	2		4		2

(a)These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.